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Abstract: We present in vivo volumetric images of human retinal micro-
circulation using Fourier-domain optical coherence tomography (Fd-OCT) 
with the  phase-variance based  motion contrast  method. Currently  fundus 
fluorescein angiography (FA) is the standard technique in clinical settings 
for  visualizing  blood  circulation  of  the  retina.  High  contrast  imaging  of 
retinal  vasculature is achieved by injection of a  fluorescein dye  into the 
systemic  circulation.  We  previously  reported  phase-variance  optical 
coherence  tomography  (pvOCT)  as  an  alternative  and  non-invasive 
technique  to  image  human  retinal  capillaries.  In  contrast  to  FA,  pvOCT 
allows  not  only  noninvasive  visualization  of  a  two-dimensional  retinal 
perfusion map but also volumetric morphology of retinal microvasculature 
with high sensitivity. In this paper we report high-speed acquisition at 125 
kHz  A-scans  with  pvOCT  to  reduce  motion  artifacts  and  increase  the 
scanning area when compared with previous reports. Two scanning schemes 
with different sampling densities and scanning areas are evaluated to find 
optimal parameters for high acquisition speed in vivo imaging. In order to 
evaluate this technique, we compare pvOCT capillary imaging at 3x3 mm
2 
and 1.5x1.5 mm
2 with fundus FA for a normal human subject. Additionally, 
a volumetric view of retinal capillaries and a stitched image acquired with 
ten 3x3 mm
2 pvOCT sub-volumes are presented. Visualization of retinal 
vasculature  with  pvOCT  has  potential  for  diagnosis  of  retinal  vascular 
diseases. 
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At present, the most widely used technique for examining the circulation of the retina in 
clinical settings is fundus fluorescein angiography (FA). This is a procedure in which the 
fundus  is  photographed  through  a  bandpass  filter  following  excitation  of  an  extrinsic 
fluorophore,  fluoroscein  sodium  (a  compound  that  fluoresces  after  absorbing  short-
wavelength light) as it is injected into the blood stream through a vein. In an effort to replace 
this invasive procedure, one commercial system (Retinal Functional Imager, Optical Imaging) 
has been developed to image retinal vasculature without use of any extrinsic contrast agents 
using a fundus camera. In this paper we concentrate on optical coherence tomography (OCT) 
[1,2] methods that have the benefit of offering perfusion maps or flow with depth information 
in the human retina [3–8]. The phase-variance based motion contrast technique for Fourier-
domain OCT (Fd-OCT) [9] has been implemented successfully in visualizing vasculature of 
the zebrafish [10], ocular circulation of the mouse [11], and human retinal vasculature [12]. 
Visualization  of  the  retinal  vasculature  and  microcirculation  is  essential  for  clinical 
diagnostics and treatment monitoring of retinal vascular diseases. The primary function of 
capillaries  in  the  eye  is  to  supply  nutrients,  exchange  respiratory  gases,  and  to  excrete 
byproducts  of  metabolic  reactions  in  the  retina.  Ocular  vascular  diseases  transform  the 
morphology  of  vessels  and  the  formation  of  capillary  networks,  angiogenesis  and  vaso-
occlusions caused by vascular endothelial cell aging, and damage associated with lifestyle-
related  illnesses  such  as  diabetes  mellitus,  hypertension,  and  heart  disease.  In  the  human 
retina, there are generally three specific layers with capillary networks. The major arterial and 
venous branches are present in the nerve fiber layer or the ganglion cell layer. In addition, two 
capillary branches of the intermediate plexus and the deeper plexus are located in between the 
inner plexiform layer and the inner nuclear layer as well as between the outer plexiform layer 
and the outer nuclear layer, respectively [13]. In histology, the lumen diameter of human 
retinal vessels has approximately ~100 µm of arteries and ~200 µm of veins close to the optic 
disk and ~15 µm of  microcapillaries in the deeper retina [14]. In a clinical environment, 
fundus FA generates vasculature maps of the retina and blood stream flow for identification of 
arteries  and  veins  as  well  as  hemorrhage.  Additionally,  commercial  system  fundus  FA 
supports relatively easy operation, fast capture, and high-resolution fundus images. In rare 
instances,  however,  FA  may  cause  adverse  reactions  in  patients  who  are  hypertensive  or 
elderly  [15].  Moreover,  patients  may  experience  nausea,  vomiting,  or  acute  hypertension 
during or after fundus FA imaging. 
In  order  to  measure  blood  flow  and  dynamics,  optical  Doppler  tomography  [16]  was 
developed to measure velocity profiles of fluid flow by detection of Doppler shifts. Doppler 
OCT demonstrated in vivo flow imaging of the rodent skin [17] and the directional color map 
of biological tissue [18]. Since then, a number of in vivo vasculature imaging techniques have 
been reported using variations of OCT including: Doppler Fd-OCT with the histogram-based 
method [19], color Doppler Fd-OCT [20], Doppler Fd-OCT with the bulk motion removal 
method [21], optical coherence angiography [22], resonant Doppler flow imaging [23], joint 
spectral and time domain OCT [24], optical micro-angiography [25], speckle variance OCT 
[26], Doppler optical frequency domain imaging [27], and dual-beam Doppler OCT [28,29]. 
Phase-variance optical coherence tomography (pvOCT) identifies regions of motion between 
consecutive B-scans, which allows mapping of micro-vasculature without quantitative flow 
information [12]. 
In this paper we present contrast agent free images of in vivo human retinal vasculature 
using phase-variance based motion contrast OCT. High-speed image acquisition at 125,000 
A-scans/s, compared to previously reported 25,000 A-scans/s [12], allows a dramatic decrease 
of motion artifacts and increases the field of view that can be imaged within a few seconds in 
a  single  volume  acquisition.  To  visualize  capillaries  in  two-  and  three-dimensions,  two 
scanning patterns are used with different sampling densities and scanning areas including 3x3 
mm
2 and 1.5x1.5 mm
2. The processed data show depth-resolved retinal micro-vascular maps 
for  different  field  sizes  and  total  acquisition  times.  Furthermore,  two-dimensional  phase-
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vasculature are presented and compared with fundus FA images. 
2. Materials and methods 
2.1. Phase-variance optical coherence tomography instrument 
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Fig. 1. Schematic of the Fourier-domain OCT instrument. The CMOS (Complementary Metal 
Oxide Semiconductor) camera is driven by a LabVIEW operating program on a workstation 
computer  through  a  frame  grabber.  Subjects  can  see  a  green  dot  from  the  fixation  target 
through the dichroic beamsplitter. SLD: Superluminescent diode. 
Figure  1  is  a  schematic  of  the  Fourier-domain  OCT  system  with  the  CMOS 
(Complementary  Metal  Oxide  Semiconductor)  line  detector  [30]  used  to  acquire  data 
presented in this paper. A superluminescent diode (Superlum, Ireland) with an 855 nm central 
wavelength and a full width half maximum of 75 nm is used as a light source. The axial 
resolution is 4.5 μm in the retina (refractive index, n = 1.38). The lateral resolution of the 
system  at  the  retina  is  estimated  at  10  μm  to  15  μm  depending  on  the  subject's  ocular 
aberrations. A standard fiber-based OCT instrument is operated in Michelson interferometer 
configuration, connecting the fiber coupler (OZ Optics, Ontario, Canada) with 90/10 splitting 
ratio. 10% of the input light is sent to the sample arm and the power of the imaging beam at 
the cornea is 350 μW. The remaining 90% of the light is sent toward the reference arm where 
it is back reflected by the mirror and passed to the detector arm where it interferes with the 
light back scattered from the sample. The reference arm length matches the sample arm length 
which is set by the position of the imaging sample. The resulting interference in the form of 
the spectral fringe pattern between the sample and the reference arm is detected in the custom-
built spectrometer. The spectrometer consists of a 75 mm focal length collimating objective, a 
1200  l/mm  diffraction  grating,  and  a  150  mm  objective  which  focuses  the  light  onto  the 
CMOS detector (spL4096-140km, Basler). The maximum line rate of the detector is 140 kHz 
at 4096 pixels and 10x10 μm (dual line) pixel size. Configuration setups of the CMOS camera 
are 4-tap, 12-bit, 80-MHz camera link clocks; the line averaging mode, a 125 kHz line rate 
and  2048  active  detector  pixels.  Subject's  gaze  is  stabilized  using  a  custom-built  fixation 
target reflected through a dichroic beamsplitter (FF662-FDi01, Semrock). The fixation target 
is composed of an 8x8 LED (light emitting diode) matrix which emits 516 nm (green) light 
and  an  electronic  controller  to  switch  fixation  light  position.  During  acquisition  with 
LabVIEW software (National Instruments), 3 to 5 seconds depending on scanning pattern 
settings, the raw data are stored in the workstation (HP xw8600, 3.2-GHz dual processors) 
with the rapid speed frame grabber (PCIe 1429, National Instruments). 
2.2. Image acquisition and data processing 
Fd-OCT  data  sets  were  acquired  in  the  Vision  Science  and  Advanced  Retinal  Imaging 
laboratory (VSRI) at the University of  California  Davis  Medical Center on a 59-year-old 
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institutional review board was obtained prior to imaging. The subject’s head position was 
fixed during acquisition using a bite-bar and forehead rest. Pupil dilation was not needed for 
imaging. Scanning areas of the retina were 3x3 mm
2 and 1.5x1.5 mm
2, as shown in Figs. 2 (a) 
and (b), respectively. Multiple B-scans at the same position, referred to as a BM-scan, were 
used to acquire the phase-change measurements required for the phase-variance contrast. In 
the 3x3 mm
2 scanning pattern, spacing between successive A-scans was 6 μm and 15 μm 
between BM-scans. Five B-scans were acquired within each BM-scan, resulting in four phase 
changes for the variance calculation at each location. For the 1.5x1.5 mm
2 scanning scheme, 4 
μm spacing between both consecutive A-scans and BM-scans was used. Due to the spatial 
oversampling between consecutive BM-scans, phase changes from within two adjacent BM-
scans were used for the variance calculations. Three B-scans were acquired within each BM-
scan in this case, producing two phase change measurements for each BM-scan. For this scan, 
phase-variance calculations utilize four phase changes from two adjacent BM-scans, allowing 
for identical statistics to the 3x3 mm
2 scan pattern. The A-line exposure time was 6.3 μs and 
the spectral data were saved in a tiff format for post-processing in LabVIEW software using 
standard  Fd-OCT  procedures  including  spectral  shaping,  zero-padding,  and  dispersion 
compensation [31–33]. All retinal images shown in this manuscript were acquired in vivo at 
125,000 axial scans (A-scan) per second. 
 
Fig. 2. Fundus color photograph of a normal human subject with OCT scanning locations. (a) 
Scanning 3x3 mm
2 of a parafoveal region. (b) Scanning 1.5x1.5 mm
2 of a perifoveal region. 
As shown in Figs. 3 (a) and (b), the Fourier transform of spectral fringes (after remapping 
to k-space) from one B-scan acquired by the CMOS detector produces a complex OCT signal 
with  intensity  and  phase  information,  respectively.  Each  B-scan  consists  of  500  A-scans 
acquired over 3 mm lateral scanning range. The dynamic range of the intensity image is 23 dB 
and the phase values vary from -π to + π. Note that one can discriminate retinal vessels, round 
shaped bright structures, in the ganglion cell layer from other retinal structures on the OCT B-
scan in Fig. 3 (a). However, since the nerve fiber layer is highly scattering as well, a simple 
maximum projection view of the retinal layers doesn't provide sufficient contrast values for 
the retinal vessels. In the Fd-OCT, any particle movement will affect phase values of the 
acquired signal. The basic concept of motion detection relies on calculating phase differences 
of the same locations between consecutive B-scans by 
  1 ( , , ) ( , , ) ( , , ) i i i x z t x z t T x z t         (1) 
which can be interpreted as flow induced phase changes in the sample. Here,  ( , , ) i x z t   is the 
phase value in the B-scans at lateral location x, depth position z, time t, and T is the time 
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11
2
11
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[ ( , , ) ( , , )]
11
NN
ii
ii
PhaseVariance x z t x z t
NN


   
     (2) 
where N represents the number of B-scans used in the calculation. The preprocessed OCT data 
sets  as  seen  in  Figs.  3  (a)  and  (b)  are  then  postprocessed  by  software  developed  at  the 
Biological Imaging Center at the California Institute of Technology to extract phase-variance 
signals as shown on Fig. 3 (d). The cross-correlation function between consecutive intensity 
images aligns each B-scan from a BM-scan in an axial direction. Average intensity images 
and phase differences are calculated from sets of B-scans acquired at the same location. The 
image presented in Fig. 3 (c) results from averaging five B-scan intensity profiles, where one 
of the five B-scans is shown in Fig. 3 (a). Phase unwrapping is applied after obtaining the 
phase difference values. Additionally, bulk motion removal and histogram-based thresholding 
processing are implemented to remove phase shifts caused by eye motion. The phase-variance 
based motion contrast procedure generates B-scans of retinal motion information illustrated in 
Fig. 3 (d). The phase-variance data explained above is processed by an algorithm developed in 
LabVIEW programming software. The differences between results presented by Fingler et al. 
and this paper are primarily limited to changes in the scan patterns, which optimize the retinal 
scanning speed, and the implementation of a high speed CMOS line camera. Further details of 
the post-possessing algorithm and details are explained in the literature [12]. 
 
Fig. 3. Fourier domain optical coherence tomography of the in vivo human retina. (a) Intensity 
image of a single B-scan. (b) Phase image  of the same single B-scan as (a). (c)  Average 
intensity image of five B-scans. (d) Phase-variance processed image using phase data from the 
same five B-scans phase data as (c). The scanning size of the lateral direction is 3 mm and the 
sampling density of the lateral direction is 6 μm. Scale bar: 500 μm. 
To visualize two- and three-dimensional vasculature networks in retinal layers, the three-
dimensional phase-variance data sets are segmented from the nerve fiber layer to the outer 
nuclear layer. The en face projection view of the segmented data produces two-dimensional 
vascular perfusion maps which are similar to the ones obtained with fundus FA. The FA 
image (1280x1024 pixels) and the color fundus image shown in this paper were acquired with 
a  Topcon  (TRC-50IX)  fundus  camera.  Moreover,  pseudo-color  (red-green-blue  (RGB)) 
coding of the processed volumetric data sets was used to better visualize three-dimensional 
vessel networks and its projection view creates two-dimensional color vasculature imaging 
linearly scaled by axial location of the vessels. 
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3.1. Retinal vascular network 
The retinal vascular flow image shown in Fig. 4 (b) was reconstructed using a projection view 
of the retinal contributions of the phase-variance Fd-OCT data. The subject was imaged with 
FA and pvOCT on his left eye. This Fd-OCT volume was acquired over a 3x3 mm
2 retinal 
area captured in approximately 3.6 seconds. Figure 4 (a) shows the fundus FA image over the 
same region for comparison. Note that the phase-variance OCT image is similar to the fundus 
FA image, showing blood vessel networks of the retina. Arteries, vein branches, and relatively 
larger vessels are equally mapped by the two imaging techniques. pvOCT shows some of the 
micro-capillaries but sampling density in this scanning scheme is not sufficient to visualize all 
of  them.  High  speed  (125  kHz)  imaging  of  the  system  allows  shorter  acquisition  time, 
resulting in around 4.5 ms acquisition for each B-scan. This reduces imaging artifacts caused 
by involuntary eye motion. The last B-scan of this volumetric scan data set was used in Fig. 3. 
 
Fig. 4. In vivo human retinal vasculature images with a normal subject. The size of imaging is 
3x3 mm
2. (a) Fluorescein angiography. (b) Projection image of phase-variance OCT retinal 
layers.  The  numbers  of  A-scans  and  B-scans  are  500  and  200,  respectively.  The  imaging 
acquisition time is 3.6 seconds. Scale bar: 500μm. 
In order to reliably  visualize  micro-circulation,  we  used  a scanning pattern  with  more 
densely sampled A-scans. In this pattern, sampling spacing is 4 μm between A-scans; BM-
scans are acquired over a 1.5x1.5 mm
2 area of the human retina. Examples obtained with this 
acquisition  scheme,  including  pvOCT  reconstructed  B-scans,  are  demonstrated  in  Fig.  5. 
Since the acquisition time of each B-scan is approximately 3.5 ms, we expect there is no 
significant eye motion between these scans. An average intensity image composed of three 
successive B-scans from a single BM-scan is shown in Fig. 5 (a). Moreover, Fig. 5 (b) shows 
the image post-processed  with the phase-variance  method from these data. The combined 
image with averaging intensity and phase variance, red color-coded is shown in Fig. 5 (c). The 
composite image validates that pvOCT identifies most of perfusion structures compared with 
the average intensity imaging where vessels can be classified by relatively bright structures. 
The  video  (Media 1)  of  the  composite  images  is  attached.  Notice  that  there  is  a  shadow 
artifact in the current phase-variance  method that produces residual phase-variance values 
below vessels. This results in non-zero phase-variance values in retinal layers where non-
perfusion should be observed including in the retinal pigmented epithelium. 
Images illustrated in Fig. 6 are acquired over 1.5x1.5 mm
2 of the human perifoveal region. 
We compare maximum projection view of pvOCT in Fig. 6 (b) to the fundus FA in Fig. 6 (a), 
acquired  at  the  same  location.  Figure  6  (b)  shows  dense  micro-capillary  networks,  not 
distinctly  recognizable  in  the  zoomed  fundus  FA  image.  The  size  of  the  smallest  
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Fig. 5. Human retinal images of phase-variance OCT data processing over 1.5 mm. (a) Average 
intensity  imaging  of  three  B-scans  from  a  single  BM-scan.  (b)  Phase-variance  image.  (c) 
Combined  image  of  average  intensity  (a)  and  red  color-coded phase-variance  imaging  (b). 
Media  1  shows  the  composite  image  over  the  1.5x1.5  mm
2  scanning  area.  The  imaging 
acquisition time of a single BM-scan containing three B-scans is approximately 10 ms. Scale 
bar: 250 μm. 
 
Fig.  6.  In  vivo  human  retinal  micro-capillary  network.  Image  size  is  1.5x1.5  mm
2.  (a) 
Fluorescein angiography. (b) Projection view of retinal contributions to pvOCT. The numbers 
of A-scans and B-scans are 375 and 360, respectively. (c) RGB depth color-coded projection 
view of retinal pvOCT data. Upper right shows depth scale bar with red color denoting a top 
layer, green showing capillaries as an intermediate vascular bed, and finally blue represents 
micro-capillaries as a deeper vascular plexus layer. The imaging acquisition time of pvOCT is 
3.5 seconds. Scale bar: 250 μm. Media 2 shows C-scan fly through of the three-dimensional 
pvOCT data set. 
resolvable capillary in this acquisition scheme is 10~12 μm. Since pvOCT includes depth 
information of capillary locations, Fig. 6 (c) shows a depth color-coded projection view. The 
pseudo-color  (RGB)  map  codes  the  linearly-scaled  axial  location  of  the  vessels.  The 
superficial capillary network, here mostly within the nerve fiber layer or the ganglion cell 
layer,  is  coded  as  red.  In  addition,  the  intermediate  capillary  plexus,  between  the  inner 
plexiform layer and the inner nuclear layer, is denoted by green. Finally, the deeper vascular 
plexus located in between the outer plexiform layer and the outer nuclear layer is colored as 
blue.  The  attached  gray-scaled  video  (Media  2)  demonstrates  depth  information  of  the 
vasculature using the pvOCT data set from the nerve fiber layer to the outer nuclear layer. The 
last B-scan of this volumetric data set was used in Fig. 5. 
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from  Fig.  6  (c).  This  image  shows  volumetric  information  of  the  vessel  network  at  the 
perifoveal  region  in  the  human  retina.  Note  again  that  the  red-colored,  larger  diameter 
capillaries  have  green  colored  shadows  underneath.  This  is  because  the  pvOCT  method 
creates the shadow artifact (non-zero phase-variance values) below relatively large vessels. 
 
Fig. 7. Three-dimensional depth color-coded image of pvOCT, using the same data presented 
in Fig. 6 (c). 
 
Fig. 8. Large field of view stitched pvOCT imaging overlaid on a fundus FA. (a) Fluorescein 
angiography. (b) Depth color-coded imaging with the ten volumes. Total image acquisition 
time for ten volumetric images is approximately 35 seconds. 
To achieve a clinically applicable imaging method, the capability to image a large field of 
view is critical. However, the scanning patterns and the acquisition speed presented in this 
paper do not allow for larger than the 3x3 mm
2 scanning area. This was because of the need to 
maintain  high-resolution  with  acquisition  time  in  a  single  volume  of  a  few  seconds.  To 
overcome this limitation, we acquired several volumes centered at different retinal locations. 
Figure 8 shows an example of the large field of view image overlaid on the fundus FA. This 
image was made from ten 3x3 mm
2 pvOCT volumes acquired by shifting the position of LED 
fixation points. After pvOCT processing, each projection image was manually aligned with 
linear translation to create a large field of view mosaic. The depth color-coded imaging in Fig. 
8 (b) approximately segmented vessels from below the inner limiting membrane to the inner 
nuclear membrane as a green color as well as from below the inner nuclear membrane to the 
outer limiting membrane as a red color. Moreover, vasculature located in the intermediate 
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images for acquisition only is 35 seconds. 
4. Conclusions 
We demonstrate feasibility of a high-speed phase-variance OCT system for two-dimensional 
visualization of the capillary network over foveal and perifoveal regions, as well as three-
dimensional representation of the vasculature in the human retina. En face visualization of the 
human foveal area with pvOCT produces details of capillary networks comparable to fundus 
FA imaging without using any contrast agents. In addition, densely scanning a small field of 
view,  1.5x1.5  mm
2,  generates  the  microcapillary  perfusion  map  and  color-coded  depth 
information of the microvasculature. pvOCT with rapid image acquisition at an A-scan speed 
of 125 kHz reduces acquisition time, hence decreasing eye motion artifacts and producing 
larger  field  of  view  imaging.  To  demonstrate  the  feasibility  of  this  technique  for  clinical 
applications,  we  showed  the  stitched  vascular  map  of  the  retina  acquired  from  multiple 
volumes. Our data suggest that pvOCT has potential in the early diagnosis of retinal vascular 
diseases including diabetic retinopathy and vascular-related macular degeneration. As further 
improvements,  shadow  artifacts  will  be  minimized  and  high-resolution  microcapillary 
networks of larger scanning areas will be visualized. 
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